FDA Seeks Input on ICH Draft on Design, Use of RWD in Safety Assessments

The FDA is proposing to adopt a new guideline from the International Council for Harmonisation (ICH) on the use of real-world data (RWD) in pharmacoepidemiological studies of drug, vaccine and other biologic products, including recommendations for high-level best practices for these studies.
Source: Drug Industry Daily